Based on the research that used depression rating scales in the elderly population, it is clear the GDS is the best validated instrument in various geriatric populations. For example, in ...

Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for depressive episodes linked to bipolar I ... measured using a depression rating scale.